#cohort	individuals	females	males	n_unknown_sex	total_hpo	total_measurements	hpo_version	gpsea_version	n_total_individual_count	n_alive	n_deceased	n_unknown_vital	n_with_age_of_last_encounter	n_with_onset	n_diseases	disease_string
ABCB7	18	0	18	0	52	0	2025-01-16	0.9.4	18	0	0	18	0	8	1	Anemia, sideroblastic, and spinocerebellar ataxia
ACADM	115	0	0	115	0	31	2025-01-16	0.9.4	115	0	0	115	0	0	1	Acyl-CoA dehydrogenase, medium chain, deficiency of
ACBD6	45	22	23	0	79	0	2023-10-09	0.9.4	45	0	0	45	0	0	1	Neurodevelopmental disorder with progressive movement abnormalities
AIRE	58	31	27	0	47	0	2025-01-16	0.9.4	58	56	2	0	2	57	1	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia
ANKRD11	337	143	175	19	48	0	2025-01-16	0.9.4	337	0	0	337	0	0	1	KBG syndrome
ASPM	22	14	8	0	17	0	2025-01-16	0.9.4	22	0	0	22	0	1	1	Microcephaly 5, primary, autosomal recessive
ATP13A2	45	18	27	0	71	0	2025-01-16	0.9.4	45	0	0	45	0	45	2	Kufor-Rakeb syndrome; Spastic paraplegia 78, autosomal recessive
ATP6V0C	31	12	19	0	83	0	2025-01-16	0.9.4	31	31	0	0	0	27	1	Epilepsy, early-onset, 3, with or without developmental delay
BRD4	18	8	10	0	40	0	2025-01-16	0.9.4	18	0	0	18	0	16	1	Cornelia de Lange syndrome 6
CHD8	79	26	53	0	81	0	2025-01-16	0.9.4	79	78	1	0	1	17	1	Intellectual developmental disorder with autism and macrocephaly
CLDN16	51	21	29	1	53	0	2025-01-16	0.9.4	51	22	0	29	0	51	1	Hypomagnesemia 3, renal
COL3A1	41	24	17	0	43	0	2025-01-16	0.9.4	41	0	0	41	0	38	2	Ehlers-Danlos syndrome, vascular type; Polymicrogyria with or without vascular-type EDS
COQ4	51	30	21	0	91	0	2025-01-16	0.9.4	51	31	19	1	19	50	2	Spastic ataxia 10, autosomal recessive; Coenzyme Q10 deficiency, primary, 7
CTCF	46	18	28	0	110	0	2025-01-16	0.9.4	46	0	0	46	0	0	1	Intellectual developmental disorder, autosomal dominant 21
CYP21A2	69	34	35	0	27	314	2025-01-16	0.9.4	69	0	0	69	0	69	1	Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
EHMT1	125	81	44	0	60	0	2025-01-16	0.9.4	125	0	0	125	0	0	1	Kleefstra syndrome 1
EZH1	19	10	8	1	106	0	2025-01-16	0.9.4	19	0	0	19	0	0	1	EZH1-related neurodevelopmental disorder
FBN1	144	57	55	32	109	0	2025-01-16	0.9.4	144	46	4	94	4	47	6	Marfan syndrome; Ectopia lentis, familial; Stiff skin syndrome; Acromicric dysplasia; Geleophysic dysplasia 2; Marfan lipodystrophy syndrome
FBXL4	95	37	58	0	91	0	2025-01-16	0.9.4	95	65	26	4	26	88	1	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)
FBXO11	56	21	35	0	128	0	2025-01-16	0.9.4	56	56	0	0	0	0	1	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities
FGD1	48	0	48	0	73	0	2025-01-16	0.9.4	48	48	0	0	0	14	1	Aarskog-Scott syndrome
FZD5	29	11	10	8	16	0	2025-01-16	0.9.4	29	29	0	0	0	29	1	Microphthalmia/coloboma 11
GLI3	82	3	7	72	34	0	2025-01-16	0.9.4	82	0	0	82	0	80	3	Pallister-Hall syndrome; Greig cephalopolysyndactyly syndrome; Polydactyly, postaxial, types A1 and B
HMGCS2	40	14	13	13	44	0	2025-01-16	0.9.4	40	23	1	16	1	40	1	HMG-CoA synthase-2 deficiency
IKZF1	82	34	37	11	66	0	2025-01-16	0.9.4	82	77	5	0	5	80	1	Immunodeficiency, common variable, 13
ITPR1	170	65	41	64	196	0	2025-01-16	0.9.4	170	113	1	56	1	144	3	Gillespie syndrome; Spinocerebellar ataxia 15; Spinocerebellar ataxia 29, congenital nonprogressive
KCNH5	27	14	13	0	28	0	2025-01-16	0.9.4	27	0	0	27	0	27	1	Developmental and epileptic encephalopathy 112
KDM6A	81	46	35	0	87	0	2025-01-16	0.9.4	81	1	0	80	0	55	1	Kabuki syndrome 2
KDM6B	73	19	54	0	251	0	2025-01-16	0.9.4	73	0	0	73	0	0	1	Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities
KMT2D	65	35	30	0	151	0	2025-01-16	0.9.4	65	53	5	7	4	31	1	Kabuki Syndrome 1
Kabuki	146	81	65	0	200	0	2025-01-16	0.9.4	146	54	5	87	4	86	2	Kabuki Syndrome 1; Kabuki syndrome 2
LDS 1 and 2	94	30	46	18	110	0	2025-01-16	0.9.4	94	58	6	30	6	20	3	Loeys-Dietz syndrome 2; Multiple self-healing squamous epithelioma, susceptibility to; Loeys-Dietz syndrome 1
LDS 1 and 3	90	29	43	18	89	0	2025-01-16	0.9.4	90	21	2	67	2	4	3	Loeys-Dietz syndrome 1; Loeys-Dietz syndrome 3; Multiple self-healing squamous epithelioma, susceptibility to
LDS 3 and 6	72	35	35	2	98	0	2025-01-16	0.9.4	72	20	0	52	0	12	3	Loeys-Dietz syndrome 6; Congenital heart defects, multiple types, 8, with or without heterotaxy; Loeys-Dietz syndrome 3
LMNA	266	150	99	17	152	0	2025-01-16	0.9.4	266	133	11	122	11	107	5	Cardiomyopathy, dilated, 1A; Emery-Dreifuss muscular dystrophy 2, autosomal dominant; LMNA-related congenital muscular dystrophy; Lipodystrophy, familial partial, type 2; Hutchinson-Gilford progeria
LZTR1	38	18	20	0	96	0	2025-01-16	0.9.4	38	35	3	0	2	25	1	Noonan syndrome 2
MAPK8IP3	20	9	11	0	93	0	2025-01-16	0.9.4	20	20	0	0	0	6	1	Neurodevelopmental disorder with or without variable brain abnormalities
MPV17	60	30	30	0	156	0	2025-01-16	0.9.4	60	21	39	0	39	60	1	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)
NBAS	67	19	21	27	134	0	2025-01-16	0.9.4	67	54	9	4	9	39	1	Short stature, optic nerve atrophy, and Pelger-Huet anomaly
NF1	419	192	169	58	36	0	2025-01-16	0.9.4	419	7	0	412	0	0	1	Neurofibromatosis, type 1
NIPBL	60	21	31	8	90	0	2025-01-16	0.9.4	60	52	0	8	0	8	1	Cornelia de Lange syndrome 1
NKX6-2	33	15	18	0	39	0	2025-01-16	0.9.4	33	0	0	33	0	33	1	Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy
PIGA	27	0	27	0	188	0	2025-01-16	0.9.4	27	0	0	27	0	19	2	Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis
POGZ	117	54	62	1	94	0	2025-01-16	0.9.4	117	109	0	8	0	13	1	White-Sutton syndrome
PPP2R1A	60	24	32	4	52	0	2025-01-16	0.9.4	60	0	0	60	0	0	1	Houge-Janssen syndrome 2
PTPN11	70	27	33	10	69	0	2025-01-16	0.9.4	70	0	0	70	0	35	3	LEOPARD syndrome 1; Noonan syndrome 1; Metachondromatosis
RERE	22	9	13	0	115	0	2025-01-16	0.9.4	22	22	0	0	0	20	1	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart
ROR2	32	3	7	22	81	0	2025-01-16	0.9.4	32	32	0	0	0	10	1	Robinow syndrome, autosomal recessive
RPGRIP1	100	45	49	6	45	0	2025-01-16	0.9.4	100	100	0	0	0	95	2	Leber congenital amaurosis 6; Cone-rod dystrophy 13
Robinow	48	10	14	24	103	0	2025-01-16	0.9.4	48	48	0	0	0	20	2	Robinow syndrome, autosomal dominant 2; Robinow syndrome, autosomal recessive
SAMD9L	31	15	16	0	41	0	2025-01-16	0.9.4	31	19	5	7	5	22	2	Spinocerebellar ataxia 49; Ataxia-pancytopenia syndrome
SATB2	158	62	90	6	11	0	2025-01-16	0.9.4	158	0	0	158	0	89	1	Glass syndrome
SCN2A	393	0	0	393	289	0	2025-01-16	0.9.4	393	0	0	393	0	277	2	Seizures, benign familial infantile, 3; Developmental and epileptic encephalopathy 11
SCO2	37	10	23	4	107	0	2025-01-16	0.9.4	37	7	24	6	24	33	2	Mitochondrial complex IV deficiency, nuclear type 2; Myopia 6
SEC61A1	19	8	11	0	76	0	2025-01-16	0.9.4	19	6	1	12	1	16	3	Immunodeficiency, common variable, 15; Tubulointerstitial kidney disease, autosomal dominant, 5; Neutropenia, severe congenital, 11, autosomal dominant
SETD2	45	18	27	0	202	0	2025-01-16	0.9.4	45	44	1	0	1	30	3	Rabin-Pappas syndrome; Luscan-Lumish syndrome; Intellectual developmental disorder, autosomal dominant 70
SF3B4	26	18	8	0	41	0	2025-01-16	0.9.4	26	0	0	26	0	0	1	Acrofacial dysostosis 1, Nager type
SLC32A1	38	19	19	0	44	0	2025-01-16	0.9.4	38	0	0	38	0	27	2	Generalized epilepsy with febrile seizures plus, type 12; Developmental and epileptic encephalopathy 114
SLC45A2	30	17	13	0	16	0	2025-01-16	0.9.4	30	0	0	30	0	0	1	Albinism, oculocutaneous, type IV
SLC4A1	33	16	16	1	49	0	2025-01-16	0.9.4	33	0	0	33	0	8	4	Distal renal tubular acidosis 4 with hemolytic anemia; Spherocytosis, type 4; Distal renal tubular acidosis 1; Cryohydrocytosis
SMAD2	23	13	8	2	89	0	2025-01-16	0.9.4	23	20	0	3	0	12	2	Loeys-Dietz syndrome 6; Congenital heart defects, multiple types, 8, with or without heterotaxy
SMAD3	49	22	27	0	30	0	2025-01-16	0.9.4	49	0	0	49	0	0	1	Loeys-Dietz syndrome 3
SMARCB1	32	12	8	12	110	0	2025-01-16	0.9.4	32	23	9	0	9	21	2	Rhabdoid tumor predisposition syndrome 1; Coffin-Siris syndrome 3
SMARCC2	65	24	37	4	118	0	2025-01-16	0.9.4	65	0	0	65	0	0	1	Coffin-Siris syndrome 8
SON	52	26	26	0	47	0	2025-01-16	0.9.4	52	0	0	52	0	0	1	ZTTK SYNDROME
SPTAN1	85	40	45	0	96	0	2025-01-16	0.9.4	85	82	3	0	3	78	4	Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia; Neuronopathy, distal hereditary motor, autosomal dominant 11; Developmental delay with or without epilepsy; Developmental and epileptic encephalopathy 5
STXBP1	462	206	220	36	516	0	2025-01-16	0.9.4	462	0	0	462	0	253	1	Developmental and epileptic encephalopathy 4
SUOX	35	11	14	10	20	0	2025-01-16	0.9.4	35	15	8	12	8	25	1	Sulfite oxidase deficiency
TBCK	41	17	24	0	97	0	2025-01-16	0.9.4	41	38	3	0	3	23	1	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3
TBX1	26	10	15	1	25	0	2025-01-16	0.9.4	26	0	0	26	0	1	1	DiGeorge syndrome
TBX5	156	56	46	54	90	0	2025-01-16	0.9.4	156	0	0	156	0	52	1	Holt-Oram syndrome
TGFB2	36	10	26	0	68	0	2024-08-13	0.9.4	36	35	1	0	1	1	1	Loeys-Dietz syndrome 4
TGFB3	75	34	41	0	73	0	2025-01-16	0.9.4	75	67	7	1	7	0	1	Loeys-Dietz syndrome 5
TGFBR1	41	7	16	18	78	0	2025-01-16	0.9.4	41	21	2	18	2	4	2	Multiple self-healing squamous epithelioma, susceptibility to; Loeys-Dietz syndrome 1
TGFBR2	53	23	30	0	96	0	2025-01-16	0.9.4	53	37	4	12	4	16	1	Loeys-Dietz syndrome 2
TRAF7	45	17	28	0	360	0	2025-01-16	0.9.4	45	0	0	45	0	0	1	Cardiac, facial, and digital anomalies with developmental delay
U2AF2	48	28	20	0	178	0	2025-01-16	0.9.4	48	46	2	0	2	26	1	Developmental delay, dysmorphic facies, and brain anomalies
UMOD	207	80	88	39	30	0	2025-01-16	0.9.4	207	0	0	207	0	104	3	Tubulointerstitial kidney disease, autosomal dominant, 1; Tubulointerstitial kidney disease, autosomal dominant, 3; Tubulointerstitial kidney disease, autosomal dominant, 2
WWOX	38	25	13	0	72	0	2025-01-16	0.9.4	38	9	11	18	11	36	2	Developmental and epileptic encephalopathy 28; Spinocerebellar ataxia, autosomal recessive 12
ZFX	19	4	14	1	203	0	2024-08-13	0.9.4	19	19	0	0	0	9	1	Intellectual developmental disorder, X-linked syndromic 37
ZMYM3	33	3	30	0	78	0	2025-01-16	0.9.4	33	32	1	0	0	26	1	Intellectual developmental disorder, X-linked 112
ZNF462	39	11	25	3	32	0	2025-01-16	0.9.4	39	0	0	39	0	0	1	Weiss-Kruszka syndrome
ZSWIM6	16	8	8	0	85	0	2023-10-09	0.9.4	16	0	0	16	0	16	2	Acromelic frontonasal dysostosis; Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features
